Listed

Angiodynamics Inc: Form 10-K/A for the period ended May 31, 2014

Filed with the SEC on Jan 8, 2015 and accepted by EDGAR at Jan 7, 2015, 21:04 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-05-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-03-01 to 2014-05-31$94.1mus-gaap:SalesRevenueNet
Revenue12 months2013-06-01 to 2014-05-31$354.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2014-03-01 to 2014-05-31$46.6mus-gaap:CostOfGoodsSold
Cost of revenue12 months2013-06-01 to 2014-05-31$174.8mus-gaap:CostOfGoodsSold
Gross profit3 months2014-03-01 to 2014-05-31$47.4mus-gaap:GrossProfit
Gross profit12 months2013-06-01 to 2014-05-31$179.7mus-gaap:GrossProfit
Research and development12 months2013-06-01 to 2014-05-31$27.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2014-03-01 to 2014-05-31$3.6mus-gaap:OperatingIncomeLoss
Operating income12 months2013-06-01 to 2014-05-31$12.9mus-gaap:OperatingIncomeLoss
Interest expense12 months2013-06-01 to 2014-05-31$3.7mus-gaap:InterestExpense
Income tax3 months2014-03-01 to 2014-05-31$3.3mus-gaap:IncomeTaxExpenseBenefit
Income tax12 months2013-06-01 to 2014-05-31$3.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-03-01 to 2014-05-31−$1.2mus-gaap:NetIncomeLoss
Net income12 months2013-06-01 to 2014-05-31$2.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-03-01 to 2014-05-31−$0.03us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2013-06-01 to 2014-05-31$0.08us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-03-01 to 2014-05-31−$0.03us-gaap:EarningsPerShareBasic
Basic EPS12 months2013-06-01 to 2014-05-31$0.08us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2013-06-01 to 2014-05-3135,439,850 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2013-06-01 to 2014-05-31$24.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2013-06-01 to 2014-05-31$11.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2013-06-01 to 2014-05-31$0us-gaap:PaymentsOfDividends
Share repurchases12 months2013-06-01 to 2014-05-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-05-31$16.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-05-31$151.7mus-gaap:AssetsCurrent
Total assetsAt period end2014-05-31$798.9mus-gaap:Assets
Current liabilitiesAt period end2014-05-31$66.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2014-05-31$262.1mus-gaap:Liabilities
Long-term debtAt period end2014-05-31$137.7mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2014-05-31$5.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-05-31$536.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001275187-15-000005. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.